CAS 57526-81-5: (-)-Prenalterol
Formula:C12H19NO3
InChI:InChI=1S/C12H19NO3/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12/h3-6,9,11,13-15H,7-8H2,1-2H3/t11-/m0/s1
InChI key:InChIKey=ADUKCCWBEDSMEB-NSHDSACASA-N
SMILES:O(C[C@H](CNC(C)C)O)C1=CC=C(O)C=C1
Synonyms:- (-)-(S)-1-(p-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol
- (S)-4-(2-Hydroxy-3-(isopropylamino)propoxy)phenol
- (S)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol
- (S)-Prenalterol
- 260-791-5
- 4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol
- 4-[2-Hydroxy-3-(Propan-2-Ylamino)Propoxy]Phenol
- 4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenol
- Cgp 7760B
- H 133/22
- Hyprenan
- See more synonyms
Sort by
Found 7 products.
Prenalterol
CAS:Controlled ProductApplications Prenalterol is a β1-adrenergic agonist and used as an cardiotonic (1,2,3). References (1) Ma, C., et al.: J. Pharm. Biomed. Anal., 47, 677 (2008)(2) Scheiber, J., et al.: J. Med. Chem., 52, 3103 (2009(3) Broadley, K., et al.: Biochem. Pharmacol., 80, 1537 (2010)Formula:C12H19NO3Color and Shape:NeatMolecular weight:225.28Prenalterol-d7
CAS:Controlled ProductApplications Labelled Prenalterol (P712700). P712700 Prenalterol is a β1-adrenergic agonist. Prenalterol is used as an cardiotonic. References Ma, C., et al.: J. Pharm. Biomed. Anal., 47, 677 (2008), Scheiber, J., et al.: J. Med. Chem., 52, 3103 (2009), Broadley, K., et al.: Biochem. Pharmacol., 80, 1537 (2010),Formula:C12D7H12NO3Color and Shape:NeatMolecular weight:232.327(±)-Prenalterol
CAS:(±)-Prenalterol (H 80/62) is an agonist of beta-2- and beta-1-adrenergic receptors and is used to study chronic congestive heart failure.Formula:C12H19NO3Purity:99.71%Color and Shape:SolidMolecular weight:225.28Prenalterol
CAS:Prenalterol is a drug that can be used to treat congestive heart failure and high blood pressure. It belongs to the class of 2-adrenergic receptor agonists, which are drugs that stimulate the sympathetic nervous system. Prenalterol has been shown to have a positive effect on the cardiovascular system by increasing cardiac output. This drug also has an anti-inflammatory effect, which may be due to its ability to inhibit protein synthesis genes in cells. Prenalterol has also been shown to reduce post-myocardial infarction remodeling by reducing myocardial fibrosis, although it does not affect the incidence of myocardial infarcts.Formula:C12H19NO3Purity:Min. 95%Color and Shape:White PowderMolecular weight:225.28 g/mol
